ACSS1
Basic information
Region (hg38): 20:25006230-25058980
Previous symbols: [ "ACAS2L" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ACSS1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 28 | 32 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 1 | |||||
Total | 0 | 0 | 28 | 4 | 2 |
Variants in ACSS1
This is a list of pathogenic ClinVar variants found in the ACSS1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
20-25007785-C-T | not specified | Uncertain significance (Jun 16, 2024) | ||
20-25007818-C-T | not specified | Likely benign (Oct 20, 2021) | ||
20-25007826-C-G | not specified | Uncertain significance (Aug 05, 2023) | ||
20-25007830-G-A | not specified | Uncertain significance (Aug 02, 2022) | ||
20-25007847-G-A | not specified | Uncertain significance (Jun 24, 2022) | ||
20-25007871-C-A | not specified | Uncertain significance (Nov 27, 2023) | ||
20-25009322-T-C | not specified | Likely benign (Jan 23, 2024) | ||
20-25009355-G-A | not specified | Uncertain significance (Aug 05, 2023) | ||
20-25009370-A-C | not specified | Uncertain significance (Oct 26, 2022) | ||
20-25012602-T-A | not specified | Uncertain significance (Nov 15, 2023) | ||
20-25012634-C-T | not specified | Uncertain significance (Jun 02, 2024) | ||
20-25012844-G-A | not specified | Uncertain significance (Nov 12, 2021) | ||
20-25012924-C-T | not specified | Uncertain significance (Oct 17, 2023) | ||
20-25013559-T-C | not specified | Uncertain significance (Dec 08, 2023) | ||
20-25013568-C-A | not specified | Uncertain significance (Jun 09, 2022) | ||
20-25013638-C-T | not specified | Uncertain significance (Mar 06, 2023) | ||
20-25013978-C-T | Benign (Mar 03, 2015) | |||
20-25014053-C-T | not specified | Uncertain significance (Jan 16, 2024) | ||
20-25020034-A-T | not specified | Uncertain significance (Mar 31, 2024) | ||
20-25020043-A-G | not specified | Uncertain significance (May 09, 2023) | ||
20-25020047-C-T | Benign (Feb 01, 2023) | |||
20-25020081-C-T | not specified | Uncertain significance (Dec 16, 2023) | ||
20-25021446-G-A | not specified | Uncertain significance (Mar 25, 2024) | ||
20-25021451-C-G | not specified | Uncertain significance (Feb 01, 2023) | ||
20-25022954-C-T | not specified | Uncertain significance (Aug 12, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ACSS1 | protein_coding | protein_coding | ENST00000323482 | 14 | 52749 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
3.08e-7 | 0.997 | 125715 | 0 | 33 | 125748 | 0.000131 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.83 | 313 | 419 | 0.748 | 0.0000248 | 4447 |
Missense in Polyphen | 109 | 179.84 | 0.60608 | 1788 | ||
Synonymous | -0.624 | 184 | 174 | 1.06 | 0.0000111 | 1410 |
Loss of Function | 2.62 | 16 | 32.0 | 0.500 | 0.00000163 | 348 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000140 | 0.000119 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000163 | 0.000163 |
Finnish | 0.000139 | 0.000139 |
European (Non-Finnish) | 0.000186 | 0.000185 |
Middle Eastern | 0.000163 | 0.000163 |
South Asian | 0.0000984 | 0.0000980 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Important for maintaining normal body temperature during fasting and for energy homeostasis. Essential for energy expenditure under ketogenic conditions (By similarity). Converts acetate to acetyl-CoA so that it can be used for oxidation through the tricarboxylic cycle to produce ATP and CO(2). {ECO:0000250, ECO:0000269|PubMed:16788062}.;
- Pathway
- Pyruvate metabolism - Homo sapiens (human);Glycolysis / Gluconeogenesis - Homo sapiens (human);Propanoate metabolism - Homo sapiens (human);Disulfiram Action Pathway;Malonyl-coa decarboxylase deficiency;Malonic Aciduria;Propanoate Metabolism;Ethanol Degradation;Methylmalonic Aciduria Due to Cobalamin-Related Disorders;Sterol Regulatory Element-Binding Proteins (SREBP) signalling;Amino Acid metabolism;Statin Pathway;Phase I - Functionalization of compounds;ethanol degradation II;acetate conversion to acetyl-CoA;Glycolysis and Gluconeogenesis;Ethanol oxidation;Biological oxidations;Metabolism;oxidative ethanol degradation III;ethanol degradation IV;Propanoate metabolism;Signaling events mediated by HDAC Class III
(Consensus)
Recessive Scores
- pRec
- 0.195
Intolerance Scores
- loftool
- 0.669
- rvis_EVS
- -0.95
- rvis_percentile_EVS
- 9.32
Haploinsufficiency Scores
- pHI
- 0.137
- hipred
- Y
- hipred_score
- 0.603
- ghis
- 0.517
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.561
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Acss1
- Phenotype
- behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); growth/size/body region phenotype; cellular phenotype; homeostasis/metabolism phenotype;
Gene ontology
- Biological process
- ethanol oxidation;acetyl-CoA biosynthetic process;acetate biosynthetic process;acetyl-CoA biosynthetic process from acetate;propionate biosynthetic process
- Cellular component
- mitochondrial matrix
- Molecular function
- acetate-CoA ligase activity;protein binding;ATP binding;AMP binding